- Home
- EDIT vs FCEL Comparison
EDIT vs FCEL Comparison
Compare EDIT & FCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- FCEL
- Stock Information
- Founded
- EDIT 2013
- FCEL 1969
- Country
- EDIT United States
- FCEL United States
- Employees
- EDIT N/A
- FCEL 584
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- FCEL Industrial Machinery/Components
- Sector
- EDIT Health Care
- FCEL Energy
- Exchange
- EDIT Nasdaq
- FCEL Nasdaq
- Market Cap
- EDIT 115.5M
- FCEL 131.2M
- IPO Year
- EDIT 2016
- FCEL 1992
- Fundamental
- Price
- EDIT $1.79
- FCEL $4.97
- Analyst Decision
- EDIT Buy
- FCEL Hold
- Analyst Count
- EDIT 13
- FCEL 6
- Target Price
- EDIT $6.73
- FCEL $14.28
- AVG Volume (30 Days)
- EDIT 1.9M
- FCEL 1.2M
- Earning Date
- EDIT 05-12-2025
- FCEL 06-06-2025
- Dividend Yield
- EDIT N/A
- FCEL N/A
- EPS Growth
- EDIT N/A
- FCEL N/A
- EPS
- EDIT N/A
- FCEL N/A
- Revenue
- EDIT $35,837,000.00
- FCEL $114,438,000.00
- Revenue This Year
- EDIT N/A
- FCEL $42.70
- Revenue Next Year
- EDIT N/A
- FCEL $10.61
- P/E Ratio
- EDIT N/A
- FCEL N/A
- Revenue Growth
- EDIT N/A
- FCEL 11.09
- 52 Week Low
- EDIT $0.91
- FCEL $3.58
- 52 Week High
- EDIT $6.22
- FCEL $30.90
- Technical
- Relative Strength Index (RSI)
- EDIT 60.00
- FCEL 54.19
- Support Level
- EDIT $1.70
- FCEL $4.04
- Resistance Level
- EDIT $1.95
- FCEL $5.84
- Average True Range (ATR)
- EDIT 0.15
- FCEL 0.53
- MACD
- EDIT 0.03
- FCEL 0.09
- Stochastic Oscillator
- EDIT 76.03
- FCEL 54.36
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company operates in USA, South Korea, Europe and Canada. Majority of revenue is from USA and South Korea.